Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole added to anti-TNF therapy for mucosal healing in Crohn's disease
2017-001737-85Phase 4Terminated
- Sponsor
- academic medical centre
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Crohn's disease comparing Albendazole + anti-TNF with Placebo + anti-TNF (2 arms). Started Apr 2018; status: terminated.
02
Drugs
albendazole
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2017-001737-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001737-85.